Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, and Okava Pharmaceuticals, Inc.

Vivani Medical, Inc. (NASDAQ:VANI) and Okava Pharmaceuticals, Inc. expanded their collaboration to include dogs in the development of OKV-119, a long-acting GLP-1 therapy for weight management, ...

Broad Arrow Auctions will offer the legendary 1954 Jaguar D-Type 'OKV 2' Works competition car, estimated at $6.5M-$8.5M, ...

OKV-119 is a miniature, subdermal, exenatide drug implant. This device can be inserted under the skin during routine veterinary visits and is being designed to provide steady doses of medication ...